CasNo.387867-13-2,cas:387867-13-2 C31H42N6O4,(387867-13-2) Suppliers

500 Gram	Negotiable

Min.Order :500 Gram
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T,Other

Keywords

cas:387867-13-2 cas:387867-13-2 C31H42N6O4 C31H42N6O4

Quick Details

Appearance:white poweder
Application:cas:387867-13-2 C31H42N6O4 technical grade or OLED grade
PackAge:Plastic vacuum packaging bag or bucket
ProductionCapacity:1|Kilogram|Day
Storage:under the cool and dry area
Transportation:by express or by sea

Superiority:

4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide Basic information

Product Name:	4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide
Synonyms:	Tandutinib(TINIBS);(4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide;4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide;4-[6-Methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-1-piperazinecarboxamide;CT 53518;MLN 518;Tandutinib for research;Tandutinib
CAS:	387867-13-2
MF:	C31H42N6O4
MW:	562.7
EINECS:
Product Categories:	API;Intermediates & Fine Chemicals;Pharmaceuticals;Tyrosine Kinase Inhibitors;ZUBRIN;Inhibitors
Mol File:	387867-13-2.mol

4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide Chemical Properties

mp	177-178°C
storage temp.	Refrigerator
CAS DataBase Reference	387867-13-2(CAS DataBase Reference)

Safety Information

MSDS Information

4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide Usage And Synthesis

Chemical Properties	White Solid
Usage	An oral, small-molecule inhibitor of FLT3 for the treatment of AML (acute myelogenous leukemia) and other cancer indications. The drug exhibited limited activity as a single agent in phase I and II clinical trials in patients with AML and myelody
Usage	antipsoratic
Usage	An oral, small-molecule inhibitor of FLT3 for the treatment of AML (acute myelogenous leukemia) clinical trials in patients with AML and myelodysplastic syndrome, but displayed promising antileukemic activity (90% complete remissions) in a phase I/II trial in patients with newly diagnosed AML w hen administered in combination with cytarabine and daunorubicin.

Our Services

1. Top Quality

2. Competitive Price

3. Fast Feedback

4. Excellent After-sale Service

5. Safe Delivery

Our Advantage

1. Risk-free guarantee,15days refund

2. Most of the products in stock,can ship within 2days after the order
3. Stable quality and supply ability,Samsung,LG,Merck,DOW,GE, supplier

4.ISO9001,ISO14001,RoSH certification

5. DUNS Registered,D-U-N-S Number :530844988,Give you the Confidence to Do Business with Us!

6. we can supply custom synthesis service.

RUIYUAN can quickly and efficiently provide a variety of organic compounds, OLED intermediates .Main including: Carbazole, Fluorene, Anthracene, Boronic acid, Naphthaline, Thiophene, Imidazole derivatives and so on. Also can provide custom synthesis from the laboratory scale to commercial production.

Company Information

sunlake. is a research-based and customer-oriented enterprise. Its professionals are dedicated to the discovery of innovative fine chemicals,specialized for Organic Photoconductors,intermediates of Liquid Crystal ,pharmaceutical ingredients,food addiitives and health products.

It’s our pleasure to support our customer to solve the mater from the product’s initial Research and Development to Kilo Lab experiments to Pilot plant production and commercial stable production.

Details:

4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide Basic information

Product Name:	4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide
Synonyms:	Tandutinib(TINIBS);(4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide;4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide;4-[6-Methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-1-piperazinecarboxamide;CT 53518;MLN 518;Tandutinib for research;Tandutinib
CAS:	387867-13-2
MF:	C31H42N6O4
MW:	562.7
EINECS:
Product Categories:	API;Intermediates & Fine Chemicals;Pharmaceuticals;Tyrosine Kinase Inhibitors;ZUBRIN;Inhibitors
Mol File:	387867-13-2.mol

4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide Chemical Properties

mp	177-178°C
storage temp.	Refrigerator
CAS DataBase Reference	387867-13-2(CAS DataBase Reference)

Safety Information

MSDS Information

4-[6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide Usage And Synthesis

Chemical Properties	White Solid
Usage	An oral, small-molecule inhibitor of FLT3 for the treatment of AML (acute myelogenous leukemia) and other cancer indications. The drug exhibited limited activity as a single agent in phase I and II clinical trials in patients with AML and myelody
Usage	antipsoratic
Usage	An oral, small-molecule inhibitor of FLT3 for the treatment of AML (acute myelogenous leukemia) clinical trials in patients with AML and myelodysplastic syndrome, but displayed promising antileukemic activity (90% complete remissions) in a phase I/II trial in patients with newly diagnosed AML w hen administered in combination with cytarabine and daunorubicin.